RWA
TTOO

Redhawk Wealth Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Redhawk Wealth Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1
Closed -$10K – 469
2019
Q2 		$10K Buy
+1
New +$11.7K ﹤0.01% 382

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Redhawk Wealth Advisors's TTOO Position: Q3 2019 in Review

Redhawk Wealth Advisors sold out of T2 Biosystems, Inc (TTOO) in Q3 2019, closing a stake of 1 share — an estimated $10K sold.

Redhawk Wealth Advisors first reported a position in TTOO in Q2 2019 and held it in 1 quarter. The position peaked at $10K in Q2 2019. 48 funds tracked by Wall St. Rank hold TTOO as of Q3 2019.

  • Redhawk Wealth Advisors reported no remaining T2 Biosystems, Inc position as of Q3 2019 after selling out during the quarter.
  • Redhawk Wealth Advisors sold 1 T2 Biosystems, Inc share in Q3 2019, an estimated $10K.
  • Redhawk Wealth Advisors first reported a position in T2 Biosystems, Inc in Q2 2019 and held it in 1 quarter.
  • Redhawk Wealth Advisors's T2 Biosystems, Inc position peaked at $10K in Q2 2019.
  • 48 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2019.

Based on Redhawk Wealth Advisors's 13F filing for Q3 2019, filed 4 Oct 2019.